Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®)
JJ · Effective Feb 7, 2021
7 active Medicare policies list 67027, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Feb 7, 2021
JM · Effective Feb 7, 2021
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Jan 1, 2025
J6 · Effective Jul 1, 2026
National · Effective Jan 1, 2025
6 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 67027 |
|---|---|---|
| Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien) | Jan 5, 2024 | Covered |
| Policy | Effective | Status of 67027 |
|---|---|---|
| Implanted Port Delivery Systems to Treat Ocular Disease | Apr 15, 2026 | Not covered |
| Policy | Effective | Status of 67027 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Oct 1, 2026 | Covered |
| Policy | Effective | Status of 67027 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Oct 1, 2026 | Covered |
| Policy | Effective | Status of 67027 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Oct 1, 2026 | Covered |
| Policy | Effective | Status of 67027 |
|---|---|---|
| Intravitreal, Punctum, and Intracameral Implants | Oct 1, 2026 | Covered |